Ever Fortune AI

Taichung, Taiwan  All Taiwan companies → Founded 2018
Clinical AI Platform Imaging AI Specialist
Critical Care Emergency Medicine Radiology
Radiology & Imaging AI Triage & ER/ICU AI
Public (listed on March 1, 2023) — 0 (has not raised any funding rounds yet)

Products

EFAI ChestSuite XR Pneumothorax Assessment System
Ever Fortune AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pneumothorax Assessment System is an FDA-cleared AI-powered radiological computer-assisted triage and notification software. It uses deep learning to analyze adult PA chest X-rays for suspected pneumothorax, sending notifications to PACS/workstations to aid in worklist prioritization and clinical assessment.

See all 1 product →

About Ever Fortune AI

Ever Fortune.AI Co., Ltd. is a technology company specializing in artificial intelligence solutions for the healthcare sector, with a strong focus on medical big data and cloud-based biomedical platforms. The company leverages advanced AI technologies to assist in diagnostics and disease prediction, aiming to optimize clinical efficiency and enhance patient outcomes. Their solutions integrate genetic, physiological, and imaging data to create comprehensive AI prediction models utilized by hospitals and medical professionals.

Ever Fortune.AI’s product portfolio includes AI-assisted interpretation systems for various medical imaging, such as radiographic bone age interpretation, height prediction, ultrasound-based tumor classification, liver cancer metastasis risk management, liver fibrosis evaluation, and cardiac arrhythmia detection. They also offer solutions for spine fracture detection, chest X-ray analysis for abnormalities like edema, consolidation, and cardiomegaly, and computer-assisted detection platforms for bone scintigraphy to identify potential bone metastases. The company is also involved in developing generative AI healthcare robots and an AI Adaptive Radiotherapy Platform, reflecting its commitment to addressing healthcare professional shortages and advancing precision medicine.

Focus Areas

AI-driven diagnostic solutions cloud biomedical platforms precision medicine medical image analysis oncology neurology cardiology pediatrics digital medicine AI-assisted diagnostics workflow optimization

Business Intelligence

Key InvestorsN/A (Publicly listed)
PartnershipsVarian, China Medical University, Kaohsiung Veterans General Hospital, Tungs' Taichung MetroHarbor Hospital, University Medical Shing Mark Hospital (Vietnam), GE, Siemens
AcquisitionsNone
TechnologyAI-driven diagnostic solutions, cloud biomedical platforms, deep learning algorithms, integration with PACS/RIS workstations, DICOM-compliant treatment planning systems, genetic algorithms, simulated annealing algorithms
FDA Clearances13 cleared products (estimated)

What Physicians Need to Know

AI-Driven Diagnostic Solutions
Ever Fortune AI offers a range of AI-powered diagnostic tools, including ECG analysis software for rapid identification of heart anomalies, ChestSuite XR Assessment System for detecting 15 abnormal findings in chest X-rays, and Computer-Assisted Detection Platforms for Bone Scintigraphy to aid in identifying potential bone metastases.
Cloud Biomedical Platforms
The company provides efficient, flexible, and scalable cloud platforms designed to enhance process improvements and monetize existing medical products. Their Pediatric Growth Assessment System, for instance, is available in cloud-based versions for various clinical settings.
Precision Medicine
Ever Fortune AI is committed to advancing precision medicine through continuous innovation in big data and artificial intelligence, aiming to revolutionize healthcare with cutting-edge digital solutions that improve patient outcomes.
Medical Image Analysis
A core specialization involves advanced AI-driven medical image analysis across various disciplines, including radiology, oncology, and cardiology, to improve diagnostic accuracy and efficiency.
Oncology Solutions
In oncology, Ever Fortune AI provides solutions like the Rtsuite Ct Hcap-Segmentation System for automatic delineation of critical organ structures in CT images for radiotherapy planning, and an AI Adaptive Radiotherapy Platform that leverages real-time data for personalized cancer treatment.
Neurology Applications
Neurology is a key focus area, with products greenlighted to serve brain neurology, contributing to the 'blue ocean' of medical AI due to high market demand and entry barriers.
Cardiology Innovations
The company offers significant innovations in cardiology, including ECG Analysis Software for rapid rhythm interpretation and the ChestSuite XR Assessment System for identifying cardiac abnormalities in chest X-rays.
Pediatric Health
Ever Fortune AI addresses pediatric health with its FDA- and TFDA-approved Bone Age Assessment System and a Pediatric Growth Assessment System that integrates multidimensional data to monitor and track children's development.
Digital Medicine
Their vision extends to digital medicine, aiming to provide solutions to medical experts anytime, anywhere, by leveraging AI and big data analysis to improve patient outcomes.
AI-Assisted Diagnostics
A primary focus is on AI-assisted diagnostics, offering auxiliary diagnostic tools that provide clinical physicians with more efficient and accurate information, reducing subjectivity in assessments.
Workflow Optimization
Ever Fortune AI's solutions are designed to optimize clinical workflows, accelerating radiotherapy planning, shortening diagnostic times, and streamlining health check scheduling, which significantly reduces patient waiting times and enhances operational efficiency.
Physician Tip

Ever Fortune AI stands out for physicians by offering AI solutions that significantly enhance diagnostic accuracy and efficiency, particularly in complex areas like oncology, neurology, and cardiology. Their tools, such as the ECG Analysis Software and Chest X-ray assessment system, provide rapid, objective insights, freeing up physician time for patient communication and complex decision-making. The company's focus on workflow optimization, including accelerated treatment planning and intelligent scheduling, directly translates to reduced administrative burden and improved patient throughput. Furthermore, their commitment to precision medicine and early detection, coupled with numerous international medical device certifications, provides a reliable and advanced suite of tools for better patient care. The ability to integrate with existing PACS systems ensures a seamless adoption into current clinical environments.

Ever Fortune AI's solutions are designed for high compatibility and seamless integration. Their radiotherapy planning systems work with any brand of treatment planning system, and their pediatric bone age assessment system can be customized to integrate with existing PACS systems in hospitals. The company is also actively collaborating with leading medical platforms and healthcare institutions in Europe and the U.S. to integrate its full suite of AI medical software.

Products by Ever Fortune AI

1 product in the directory

EFAI ChestSuite XR Pneumothorax Assessment System
Ever Fortune AI Co.
Radiology & Imaging AI
The EFAI ChestSuite XR Pneumothorax Assessment System is an FDA-cleared AI-powered radiological computer-assisted triage and notification software. It uses deep learning to analyze adult PA chest X-rays for suspected pneumothorax, sending notifications to PACS/workstations to aid in worklist prioritization and clinical assessment.

What the Web Says

Ever Fortune AI appears to be a relatively new or niche company, as comprehensive reviews across major platforms like G2, Glassdoor, Capterra, and Reddit are scarce. Information regarding specific product reviews or detailed employer experiences is limited, making a definitive assessment challenging. The company's focus seems to be within the healthcare AI sector, but without more user-generated content, a deep dive into their offerings or workplace culture is not possible.

Overall: Mixed

Strengths

  • Unknown due to lack of reviews.
  • Potential for innovation in healthcare AI (based on company name/focus).
  • Likely targeting a specialized market.

Limitations

  • Lack of public reviews on major platforms (G2, Glassdoor, Capterra, Reddit).
  • Limited information available about products or services.
  • No discernible employer reviews or insights into company culture.
  • Difficulty in assessing product effectiveness or customer satisfaction.
  • Unclear market presence or user adoption.

Based on reviews from: G2 (no significant reviews found), Glassdoor (no significant reviews found), Capterra (no significant reviews found), Healthcare IT reviewers (no prominent reviews found for 'Ever Fortune AI'), Reddit (no significant discussions or reviews found)

Last updated: 2026-07-18

Videos

News, demos, and interviews about Ever Fortune AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ever Fortune AI →

View all on YouTube

Press & Coverage

Healthcare+ B2B
EVER FORTUNE AI Targets ASEAN and Western Markets with AI Medical Products, Aiming for Exponential Growth in 2025
EVER FORTUNE AI plans significant expansion into ASEAN markets, Europe, and the US in 2025, following a 270% revenue increase in 2024. The company has secured 43 medical device approvals worldwide, including 12 FDA clearances, and is partnering to establish Vietnam's first smart hospital.
2025-01
FDA.report
Ever Fortune.AI Co., Ltd. September 25, 2023 Ti-Hao Wang Chief Technology Officer 8 F., No. 573, Sec. 2, Taiwan Blvd., West - FDA.report
This document details the FDA's substantial equivalence determination for Ever Fortune.AI's EFAI RTSuite CT HCAP-Segmentation System, a software designed to automatically delineate organs-at-risk on CT images for radiation therapy. The device is intended for use by trained radiation oncology professionals.
2023-09
digitimes
Taiwan's Ever Fortune partners with GE and Siemens, eyes Southeast Asia - digitimes
Ever Fortune AI, an AI medical imaging solutions company, is looking to expand its presence in Southeast Asia and has partnered with GE and Siemens.
2024-02
RecallHawk
Ever Fortune.Ai, Co., Ltd. u2014 FDA Actions - RecallHawk
This page lists all FDA recalls and clearances for Ever Fortune.Ai, Co., Ltd., including various AI-powered assessment systems for conditions like appendicitis, bone age, and pleural effusion.
unknown
Healthcare+ Expo, Taiwan
EF: integrates smart medicine and technology - Healthcare+ Expo, Taiwan
Ever Fortune AI, a team of clinical physicians, AI solution architects, and data scientists, integrates AI to enhance medical diagnoses, deliver personalized care, and manage medical data. They utilize NVIDIA Deep Learning Supercomputer DGX-2 and have developed systems for bone age assessment, breast tumor classification, and liver fibrosis assessment since 2017.
2019-10

Frequently Asked Questions

Ever Fortune AI provides a range of AI-driven diagnostic solutions, including the 'EFAI RT Suite CT HCAP-Segmentation System' for oncology radiation planning and a Computer-Assisted Detection Platform for Bone Scintigraphy to identify bone metastases. For cardiology, they offer ECG Analysis Software and Cardiosuite SPECT Myocardial Perfusion Agile Workflows, alongside a Chest X-ray Solution that detects 15 abnormal findings. Additionally, their Pediatric Growth Assessment System uses AI for bone age interpretation and growth trend reports, and they have solutions for brain hemorrhage detection.
Ever Fortune AI specializes in cloud-based biomedical platforms designed to enhance operational efficiency and facilitate precision medicine. These platforms offer modular, flexible, and scalable deployment options, including cloud, on-premises, or hybrid systems, compatible with major cloud providers like AWS, Azure, or GCP to meet local compliance and security needs. Their 'Gene Meta Platform' integrates genetic testing expertise with AI algorithms for personalized risk assessment, supporting customized precision services.
Ever Fortune AI prioritizes regulatory compliance, holding 41 medical device certifications globally, including 12 FDA clearances in the U.S. and 16 TFDA approvals in Taiwan. Their products, such as the 'EFAI Bonesuite XR Bone Age Pro Assessment System' and 'EFAI PACS Picture Archiving and Communication System,' are designed and validated in compliance with standards like 21 CFR Part 820.30 and ISO 14971:2019. For data security, their cloud platforms are built to integrate with major cloud providers, ensuring adherence to local compliance and security protocols.
Ever Fortune AI has established significant partnerships with leading medical institutions and technology providers, including Varian, China Medical University, GE, and Siemens. They are actively expanding their market presence, collaborating with medical platforms in Europe and the U.S., and forming strategic alliances in ASEAN markets like Vietnam, Thailand, and Malaysia. The company is also an NVIDIA Asia Medical AI software development partner, demonstrating its commitment to global expansion and technological collaboration.
Ever Fortune AI's solutions are designed to streamline clinical workflows by providing AI-assisted diagnostics and intelligent management systems. For instance, their AI Adaptive Radiotherapy Platform dynamically adjusts treatment plans and rapidly segments imaging, reducing patient waiting times and allowing medical teams to focus on complex decisions. Additionally, their Intelligent Health Check Scheduling System uses AI to optimize procedures and resource allocation, eliminating bottlenecks and improving operational efficiency.
While specific pricing models for Ever Fortune AI's solutions are not explicitly detailed, the broader AI industry is increasingly moving towards flexible 'pay-per-use' or subscription-based models. This trend is driven by the high operational costs of AI infrastructure, such as GPUs, and aims to monetize investments while offering scalable access to advanced AI capabilities. Healthcare providers can expect models that align with usage or tiered service levels.
Ever Fortune AI has demonstrated robust financial growth, with significant year-on-year revenue increases and analysts projecting profitability. The company is publicly traded and has secured substantial medical device approvals, indicating a strong market position and commitment to innovation. Their long-term vision includes pioneering digital healthcare, developing generative AI healthcare robots, and expanding globally to address the shortage of healthcare professionals and advance automation in medicine.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.